Fig. 6
From: Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice
Anti-ERMAP mAb-treated AD mice have increased levels of anti-Aβ Abs in the serum. 3XTg-AD mice were injected i.p. with anti-ERMAP and control isotype Ab as in Fig. 3. Three and a half months later, the levels of anti-Aβ40 and anti-Aβ42 Abs in the serum were measured by ELISA. The data are expressed as mean ± SD from one of three independent experiments with similar results (5–8 mice per group in each experiment). *P < 0.05 versus control isotype Ab group